|
Type 2 Diabetes And Obesity Research - ZenBio, Inc. Awarded $1.38 Million Phase II SBIR Grant For Sk |
|
|
|
Written by Webmaster
|
|
Thursday, 02 October 2008 |
|
More info...
ZenBio, Inc. announced that it has been awarded a Phase II SBIR grant to commercialize their primary human skeletal myocyte and adipocyte co-culture system. The $1.38 million award from the National Institutes of Health will fund the continued optimization and commercial development of this unique tool for type 2 diabetes and obesity research.
UK Ranked 2nd For Diabetes Care In The First Euro Consumer Diabetes Index; Trails Denmark (Medical News Today)
British diabetes care is the 2nd best in Europe, according to the first Euro Consumer Diabetes Index. Denmark leads the Index ranking, UK being the runner-up, only one point behind and ahead of France.
Diabetes Share Your Opinion. (0 posts)
|
|
Last Updated ( Thursday, 02 October 2008 )
|
